首頁 > 市場調查報告書 > 醫療設備

眼科設備隱形眼鏡

市場調查報告書

商品編碼

1289776

全球下一代隱形眼鏡和視覺支架市場 - 2023-2030年

Global Next Generation Contact Lenses and Visual Prostheses Market - 2023-2030

出版日期: 2023年06月12日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球下一代隱形眼鏡和視覺假體市場在2022年達到1.725億美元，預計到2030年將見證有利可圖的成長，達到6.08億美元。在預測期內（2023-2030），全球下一代隱形眼鏡和視覺修復器市場預計將呈現17.7%的複合年成長率。

下一代隱形眼鏡比傳統的隱形眼鏡更先進，可以糾正更廣泛的視力問題。下一代隱形眼鏡和視覺義肢是在眼睛的天然晶狀體被摘除或損壞後取代其功能的設備。它們可用於治療白內障、青光眼和其他眼部疾病。

老年人口中視網膜疾病發病率的上升是下一代隱形眼鏡和視覺修復器市場的主要驅動力之一。最普遍的視網膜疾病是AMD、高血壓視網膜病變、視網膜外膜、BRVO和糖尿病視網膜病變。

市場動態

與眼睛有關的疾病的發病率不斷上升

在全球範圍內，特別是在印度，眼睛疾病的頻率正在上升。例如，根據世界衛生組織（WHO）的數據，全世界至少有22億人患有近視或遠視。根據世界衛生組織的說法，如果病人得到適當的診斷和護理，至少有10億例視力損傷可能會被避免。

由於緊張的生活方式，印度的視力下降病例正在上升。根據一項大規模的研究，其中包括14.5萬名患者的數據，2019年干眼症的病例增加到21000例。報告指出，印度正處於乾眼症流行的邊緣。到2030年，它將影響約40%的城市人口。

眼科醫生的短缺

儘管近年來，對眼科醫生的需求急劇擴大。這在不已開發國家尤為明顯。例如，在印度，每90,000人就有一名眼科醫生，但美國的比例是1：15。每百萬人的平均眼科醫生數量因經濟發展而異，從低收入國家的每百萬人9名到高收入國家的79名。

COVID-19影響分析

這場大流行阻礙了下一代隱形眼鏡研究和開發的進展。封鎖、社會疏遠策略和受限的融資前景造成了實驗室和研究設施的中斷。這可能會推後將新的創新產品推向市場的時間尺度。

大流行病對全球供應鏈產生了重大影響，促使許多項目的生產和交付中斷。這些中斷有可能影響下一代隱形眼鏡的製造和供應，包括材料、部件和製造設備的採購。

Market Overview

The Global Next Generation Contact Lenses And Visual Prostheses Market reached US$ 172.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 608.0 million by 2030. The global next generation contact lenses and visual prostheses market is expected to exhibit a CAGR of 17.7% during the forecast period (2023-2030).

Next-generation contact lenses are more advanced than traditional contact lenses and can correct a wider range of vision problems. next-generation contact lenses and visual prostheses are devices that replace the function of the eye's natural lens after it has been removed or damaged. They can be used to treat cataracts, glaucoma, and other eye conditions.

The rising prevalence of retinal diseases amongst the geriatric population is one of the major drivers for the next generation contact lenses & visual prostheses market. The most prevalent retinal diseases are AMD, hypertensive retinopathy, epiretinal membrane, BRVO, and diabetic retinopathy.

Market Dynamics

Rising Prevalence of Eye Related Diseases

The frequency of eye diseases is increasing globally, particularly in India. For instance, according to the World Health Organization (WHO), at least 2.2 billion people worldwide suffer from near- or far-sightedness. According to the World Health Organization, if the patient had received the proper diagnosis and care, at least one billion cases of vision impairment may have been avoided.

Due to a hectic lifestyle, cases of vision loss are on the rise in India. According to a large-scale study, which included data from 14.5 lakh patients, the number of cases of dry eye disease increased to 21,000 in 2019. It states that India is on the verge of a dry eye disease epidemic. By 2030, it will affect approximately 40% of the urban population.

Shortage of Ophthalmologists

Although the need for ophthalmologists has expanded dramatically in recent years. This is especially noticeable in underdeveloped nations. In India, for example, there is one ophthalmologist for every 90,000 people, but the US has a ratio of 1:15. The average number of ophthalmologists per million people varies according to economic development, ranging from 9 per million in low-income nations to 79 million in high-income countries.

COVID-19 Impact Analysis

The pandemic has hampered the advancement of next-generation contact lens research and development. Lockdowns, social distancing tactics, and restricted financing prospects have caused disruptions in laboratories and research facilities. This might possibly push back the timescale for bringing new innovations to market.

The pandemic has had a substantial impact on the global supply chain, causing interruptions in the manufacture and delivery of many items. These disruptions have the potential to influence the manufacture and availability of next-generation contact lenses, including the procurement of materials, components, and manufacturing equipment.

Segment Analysis

The global next generation contact lenses and visual prostheses market is segmented based on type of product , type of diseases and end user .

The Contact Lens Segment will be Dominated by Market Players During the Forecast Period

Contact lens is expected to be the dominating segment with the percentage around 81.3% in the forecast period as a result of product launches and approvals. For instance, Alcon Canada, for example, introduced new total toric lenses for astigmatic patients. Alcon, a worldwide pioneer in eye care devoted to helping people see brilliantly, announced the Canadian debut of a total of 30 for Astigmatism and Dailies Total 1 Astigmatism.

Alcon's line of reusable and daily disposable lenses has been expanded with high-performing solutions targeted at astigmatic patients. According to estimates, toric lenses (for astigmatic correction) are the fastest expanding section of the contact lens industry, providing an opportunity for eye care specialists to deliver excellent vision correction and patient care.

Geographical Analysis

North America is the Dominating Region During the Forecast Period

North America dominates the market for next-generation contact lenses and visual prostheses accounting for 42.1% and this trend is expected to continue during the projected period. The region's dominance is likely to continue during the projection period, owing to factors such as rising diabetes incidence, high disposable income, and growing awareness of modern technology for the treatment of eyesight impairment.

Due to factors such as improved healthcare infrastructure and the availability of innovative medicines for treating blindness, as well as economic expansion in countries such as India and China, the Asia Pacific area is expected to be the fastest-growing regional sector throughout the projection period.

Competitive Landscape

The major global players include: Johnson & Johnson, NIDEK, Novartis, Second Sight, NJ Retina, Interojo, OcuMedic, Bausch & Lomb, Pixium Vision, Menicon, and others.

Why Purchase the Report?
To visualize the global next generation contact lenses and visual prostheses market segmentation based on the type of product, type of diseases, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global next generation contact lenses and visual prostheses market level with all segments.
Pdf report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global next generation contact lenses and visual prostheses market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by type of product
3.2. Snippet by type of diseases

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rising prevalence of retinal diseases amongst the geriatric population
- 4.1.2. Restraints
  - 4.1.2.1. Shortage of Expert ophthalmologists
- 4.1.3. Opportunity
  - 4.1.3.1. Increasing product launches and approvals
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Type of Product

7.1 Contact lens
7.2 Visual Prostheses

8. By Type of Diseases

8.1. Glaucoma
8.2. Diabetes
8.3. AMD
8.4. Retinitis Pigmentosa
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. The U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. The UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country